glp 1 drugs and breast cancer The Impact Safety of GLP‐1 Agents and Can GLP-1 Drugs Help Manage

DSIP is not approved for human use by the FDA or any regulatory agency

Aliment Pharmacol Ther 2004;19:537-544

They are not approved, intended, or suitable for human or animal consumption, medical use, or diagnostic applications of any kind

Here are a few things safety-wise to keep in mind: Skin reactions : Wearing an adhesive patch for extended periods may cause irritation, redness, or contact dermatitis, especially with products that havent undergone dermatological testing

The Latest in GLP-1 Research & Innovation As a trusted name in transdermal supplementation, PatchMD remains at the forefront of scientific advancements in weight management support

As such, speak with a doctor before taking supplements if you are nursing